Phenotypic Expansion of Autosomal Dominant LZTR1-Related Disorders with Special Emphasis on Adult-Onset Features
- PMID: 39062695
- PMCID: PMC11276570
- DOI: 10.3390/genes15070916
Phenotypic Expansion of Autosomal Dominant LZTR1-Related Disorders with Special Emphasis on Adult-Onset Features
Abstract
Leucine zipper-like transcription regulator 1 (LZTR1) acts as a negative factor that suppresses RAS function and MAPK signaling; mutations in this protein may dysregulate RAS ubiquitination and lead to impaired degradation of RAS superfamily proteins. Germline LZTR1 variants are reported in Noonan syndrome, either autosomal dominant or autosomal recessive, and in susceptibility to schwannomatosis. This article explores the genetic and phenotypic diversity of the autosomal dominant LZTR1-related disorders, compiling a cohort of previously published patients (51 with the Noonan phenotype and 123 with schwannomatosis) and presenting two additional adult-onset cases: a male with schwannomatosis and Parkinson's disease and a female with Noonan syndrome, generalized joint hypermobility, and breast cancer. This review confirms that autosomal dominant LZTR1-related disorders exhibit an extreme phenotypic variability, ranging from relatively mild manifestations to severe and multi-systemic involvement, and offers updated frequences of each clinical feature. The aim is to precisely define the clinical spectrum of LZTR1-related diseases, using also two new emblematic clinical cases. Gaining insight into the mechanisms underneath this variability is crucial to achieve precision diagnostics and the development of therapeutic interventions.
Keywords: LZTR1; Noonan syndrome; generalized joint hypermobility; schwannomatosis.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Dysregulation of RAS proteostasis by autosomal-dominant LZTR1 mutation induces Noonan syndrome-like phenotypes in mice.JCI Insight. 2024 Nov 22;9(22):e182382. doi: 10.1172/jci.insight.182382. JCI Insight. 2024. PMID: 39352760 Free PMC article.
-
Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules.Genet Med. 2024 Nov;26(11):101241. doi: 10.1016/j.gim.2024.101241. Epub 2024 Aug 10. Genet Med. 2024. PMID: 39140257
-
Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling.Hum Mol Genet. 2019 Mar 15;28(6):1007-1022. doi: 10.1093/hmg/ddy412. Hum Mol Genet. 2019. PMID: 30481304
-
LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.BMC Med Genomics. 2022 Jul 15;15(1):160. doi: 10.1186/s12920-022-01304-x. BMC Med Genomics. 2022. PMID: 35840934 Free PMC article. Review.
-
A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review.BMC Endocr Disord. 2021 Jan 6;21(1):2. doi: 10.1186/s12902-020-00666-6. BMC Endocr Disord. 2021. PMID: 33407364 Free PMC article. Review.
Cited by
-
Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis.Clin Cancer Res. 2025 Apr 14;31(8):1400-1406. doi: 10.1158/1078-0432.CCR-24-3278. Clin Cancer Res. 2025. PMID: 39937237
-
GH Therapy in Non-Growth Hormone-Deficient Children.Children (Basel). 2024 Dec 24;12(1):3. doi: 10.3390/children12010003. Children (Basel). 2024. PMID: 39857834 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources